Financials Genes Tech Group Holdings Company Limited

Equities

8257

KYG3825A1076

Semiconductors

Delayed Hong Kong S.E. 04:08:22 2024-04-29 am EDT 5-day change 1st Jan Change
0.056 HKD 0.00% Intraday chart for Genes Tech Group Holdings Company Limited -5.08% -17.65%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 780.7 921.5 1,087 632.7 391.4 267.2
Enterprise Value (EV) 1 934.7 1,581 1,744 1,114 831.7 750.4
P/E ratio 14 x 5.15 x 7.54 x 7.97 x -4.87 x 2.95 x
Yield 5.12% - 3.68% - - -
Capitalization / Revenue 0.7 x 0.48 x 0.73 x 0.42 x 0.24 x 0.2 x
EV / Revenue 0.83 x 0.83 x 1.16 x 0.74 x 0.52 x 0.56 x
EV / EBITDA 9.42 x 4.99 x 7.82 x 7 x 4.17 x 4.56 x
EV / FCF 7.02 x -4.92 x -84.1 x 4.72 x 2.79 x -10.7 x
FCF Yield 14.2% -20.3% -1.19% 21.2% 35.9% -9.39%
Price to Book 1.6 x 1.47 x 1.41 x 0.79 x 0.55 x 0.33 x
Nbr of stocks (in thousands) 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000
Reference price 2 0.7807 0.9215 1.087 0.6327 0.3914 0.2672
Announcement Date 3/27/19 3/18/20 3/24/21 3/28/22 3/22/23 3/21/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,122 1,908 1,498 1,497 1,599 1,333
EBITDA 1 99.18 317 223.1 159 199.3 164.4
EBIT 1 84.2 297.3 197.8 130.4 173.9 139.4
Operating Margin 7.5% 15.58% 13.21% 8.71% 10.87% 10.46%
Earnings before Tax (EBT) 1 88.81 260.4 196.6 118.4 -82.38 126.3
Net income 1 55.6 179 144.2 79.4 -80.44 90.64
Net margin 4.96% 9.38% 9.63% 5.3% -5.03% 6.8%
EPS 2 0.0556 0.1790 0.1442 0.0794 -0.0804 0.0906
Free Cash Flow 1 133.1 -321 -20.73 235.8 298.4 -70.44
FCF margin 11.86% -16.82% -1.38% 15.75% 18.66% -5.28%
FCF Conversion (EBITDA) 134.2% - - 148.29% 149.72% -
FCF Conversion (Net income) 239.39% - - 296.98% - -
Dividend per Share 2 0.0400 - 0.0400 - - -
Announcement Date 3/27/19 3/18/20 3/24/21 3/28/22 3/22/23 3/21/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 154 659 657 481 440 483
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.553 x 2.08 x 2.945 x 3.024 x 2.209 x 2.939 x
Free Cash Flow 1 133 -321 -20.7 236 298 -70.4
ROE (net income / shareholders' equity) 11.6% 32.1% 20.7% 10.1% -10.6% 11.9%
ROA (Net income/ Total Assets) 2.55% 7.37% 4.99% 3.24% 4.31% 3.8%
Assets 1 2,182 2,428 2,890 2,448 -1,868 2,385
Book Value Per Share 2 0.4900 0.6300 0.7700 0.8000 0.7100 0.8100
Cash Flow per Share 2 0.2800 0.1400 0.1000 0.1700 0.2400 0.1500
Capex 1 25.5 58.3 32.5 5.21 17 6.86
Capex / Sales 2.27% 3.05% 2.17% 0.35% 1.06% 0.51%
Announcement Date 3/27/19 3/18/20 3/24/21 3/28/22 3/22/23 3/21/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 8257 Stock
  4. Financials Genes Tech Group Holdings Company Limited